RBD8088 / Suzhou Ribo - LARVOL DELTA

Effects of a BBB-penetrating oligonucleotide drug, RBD8088, in mouse models of human glioblastoma (ESMO 2024) - "RBD8088 penetrates BBB and express a therapeutic effect in a targeted manner in mouse models of GBM. RBD8088 is currently undergoing further preclinical validation and development aiming for CTA/IND application in the near future."

Preclinical • Brain Cancer • CNS Tumor • Glioblastoma • Oncology • Solid Tumor